23 August 2023 - Responses to the first public consultation for the HTA Review (Consultation 1) have now been published ...
12 May 2023 - Consultation on the draft 2023-24 Cost Recovery Implementation Statement (CRIS) for listing medicines on the Pharmaceutical ...
2 February 2022 - Since August 2021, the Committee has heard from nearly 200 stakeholders through bilateral interviews and virtual group ...
7 September 2021 - Consumer involvement in Australia’s medicines choices has been further strengthened under a new strategic agreement Medicines ...
24 June 2021 - It was an emotional evening among the nearly 200 in-person and online attendees at Parliament House last ...
18 June 2021 - The efficient funding of chemotherapy review discussion paper was released on 21 May 2021 to gain ...
18 January 2021 - Historically, Australia has been at the forefront of the application of HTA for assessing the effectiveness and ...
13 October 2020 - On 21 September 2020, the department hosted a webinar to provide information to industry on the ...
20 May 2020 - As outlined in the April 2020 PBS news item – ‘Cost Recovery – Consultation Feedback’, the current ...
28 April 2020 - On 12 February 2020, the Department hosted a webinar to commence broad consultation on proposed fee changes ...
29 October 2019 - Private health insurers are pushing for reform of the healthcare system to allow them to pay ...
17 August 2018 - The PBAC minutes pertaining to the draft review report for the post-market review of the use of ...
12 July 2018 - The Consumers Health Forum today introduces an innovative online mechanism to gauge community trust in health ...
21 May 2018 - PD-1 and PD-L1 checkpoint inhibitor immunotherapies: options for subsidy consideration for multiple cancer types. ...
17 May 2018 - The Consumers Health Forum will urge the government to ensure the next negotiations for the Community ...